BANK VONTOBEL/CALL/ELI LILLY & CO/640/0.1/21.06.24 Share Price

Warrant

DE000VM09Z43

Market Closed - Deutsche Boerse AG 11:35:27 14/06/2024 pm IST
22.44 EUR +0.45% Intraday chart for BANK VONTOBEL/CALL/ELI LILLY & CO/640/0.1/21.06.24
Current month+38.26%
1 month+93.95%
Date Price Change
14/24/14 22.44 +0.45%
13/24/13 22.34 +7.46%
12/24/12 20.79 -1.09%
11/24/11 21.02 +0.86%
10/24/10 20.84 +4.83%

Delayed Quote Deutsche Boerse AG

Last update June 14, 2024 at 11:35 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer Vontobel Vontobel
WKN VM09Z4
ISINDE000VM09Z43
Date issued 16/08/2023
Strike 640 $
Maturity 21/06/2024 (5 Days)
Parity 10 : 1
Emission price 2.41
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 23.26
Lowest since issue 2.12
Delta0.96x
Omega 3.517
Premium0.37x
Gearing3.65x
Moneyness 1.370
Difference Strike -238.5 $
Difference Strike %-37.26%
Spread 0.02
Spread %0.09%
Intrinsic value 22.28

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
878.4 USD
Average target price
855.4 USD
Spread / Average Target
-2.63%
Consensus